NanoViricides
NNVC
#10110
Rank
A$34.86 M
Marketcap
A$1.94
Share price
4.52%
Change (1 day)
-16.66%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): A-$0.93

According to NanoViricides's latest financial reports the company's current EPS (TTM) is A-$0.92. In 2024 the company made an earnings per share (EPS) of A-$1.05 an increase over its 2023 EPS that were of A-$1.12.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.93-11.52%
2024A-$1.05-5.41%
2023A-$1.125.71%
2022A-$1.05-13.58%
2021A-$1.22-66.11%
2020A-$3.601.7%
2019A-$3.54-10.98%
2018A-$3.98-22.35%
2017A-$5.12-10.53%
2016A-$5.73375%
2015A-$1.21-85.19%
2014A-$8.1442.11%
2013A-$5.7326.67%
2012A-$4.52-6.25%
2011A-$4.8214.28%
2010A-$4.22100%
2009A-$2.11-0%
2008A-$2.11-33.33%
2007A-$3.16-0%
2006A-$3.164445.07%
2005A-$0.06962

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
A-$0.07534-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$3.19-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.82-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.48-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.44-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.42-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK